Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6142-6153
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6142
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6142
Table 2 Laboratory parameters of the inflammatory bowel disease group and the control group
Parameter | IBD group (n = 50) | Control group (n = 50) | P value1 |
Erythrocytes (× 1012/L) | 4.7 ± 0.5 | 5.0 ± 0.4 | 0.020 |
Hemoglobin (g/L) | 140.4 ± 17.3 | 148.1 ± 13.7 | 0.015 |
Fasting glucose (mmol/L) | 5.1 ± 0.9 | 5.0 ± 0.6 | 0.653 |
Urea (mmol/L) | 4.7 ± 1.5 | 5.6 ± 1.6 | 0.004 |
Creatinine (μmol/L) | 71.4 ± 15.3 | 75.9 ± 14.7 | 0.134 |
Total proteins (g/L) | 71.2 ± 6.6 | 72.1 ± 3.9 | 0.394 |
Albumins (g/L) | 39.5 ± 5.1 | 43.7 ± 2.4 | < 0.001 |
hsCRP (mg/L) | 3.4 ± 2.6 | 1.2 ± 1.1 | < 0.001 |
Triglycerides (mmol/L) | 1.3 ± 0.9 | 1.1 ± 0.6 | 0.311 |
Total cholesterol (mmol/L) | 4.8 ± 1.3 | 5.2 ± 1.2 | 0.091 |
HDL cholesterol (mmol/L) | 1.3 ± 0.4 | 1.4 ± 0.3 | 0.447 |
LDL cholesterol (mmol/L) | 2.6 (2.1-3.4) | 3.2 (2.4-3.9) | 0.018 |
FC (μg/g) | 231 (61.5-619.2) | - | - |
- Citation: Alicic D, Martinovic D, Rusic D, Zivkovic PM, Tadin Hadjina I, Vilovic M, Kumric M, Tokic D, Supe-Domic D, Lupi-Ferandin S, Bozic J. Urotensin II levels in patients with inflammatory bowel disease. World J Gastroenterol 2021; 27(36): 6142-6153
- URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6142.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6142